Novo Nordisk AS (NVO)
80.99
+0.84
(+1.05%)
USD |
NYSE |
Mar 18, 16:00
80.97
-0.02
(-0.02%)
After-Hours: 19:55
Novo Nordisk Market Cap: 359.52B for March 18, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion Biotech AS | 11.72M |
| Ascendis Pharma AS | 9.907B |
| Zealand Pharma AS | 5.793B |
| Viking Therapeutics Inc | 3.309B |
| DBV Technologies SA | 99.30M |
Market Cap Related Metrics
| PE Ratio | 24.67 |
| PS Ratio | 8.585 |
| PEG Ratio | 1.150 |
| Price to Book Value | 17.96 |
| Price to Free Cash Flow | 35.76 |
| Price | 80.99 |
| Earnings Yield | 4.05% |
| PEGY Ratio | 1.060 |
| Operating PE Ratio | 19.41 |
| Normalized PE Ratio | 24.67 |